Gefjon Pharma ApS

CVR 44512971 · Private limited company (ApS) · Active · Low risk

Gefjon Pharma ApS is a Private limited company (ApS), founded on , based in København N. The company is registered in the industry fremstilling af farmaceutiske præparater. Our model estimates a bankruptcy risk of 0.6% over the next 12 months, which is 0.4 times the average for Danish companies. 2 annual reports have been published, of which 1 more than six months after the end of the financial year. The latest annual report (31 Mar 2026) shows equity of DKK -5.0m and a net result of DKK -4.2m. CEO: Thomas Frees Buthler, Anders Miki Bojesen, Fabio Antenucci.

Bankruptcy risk for Gefjon Pharma ApS

0.6%
probability of bankruptcy within 12 months
Low risk

0.4 × the average (1.41%) · higher risk than 66% of active Danish companies

Lowest riskHighest risk

Increases the risk

Equity ratio< -50% · bankruptcy rate 19.3%2.2×
Age (years)2 yrs · bankruptcy rate 18.9%2.1×
Share of late annual reports50%–75% · bankruptcy rate 18.4%2.1×
Negative equityYes · bankruptcy rate 17.5%2.0×
Equity vs. share capital< 0× · bankruptcy rate 17.3%2.0×
Published annual reports2 · bankruptcy rate 16.7%1.9×
Return on assets< -20% · bankruptcy rate 16.7%1.9×
Time since new CEO1 yrs · bankruptcy rate 16.2%1.8×

Reduces the risk

Auditor's statementExtended review · bankruptcy rate 2.9%0.33×
Current ratio200%–500% · bankruptcy rate 3.4%0.39×
Number of CEOs3+ · bankruptcy rate 4.0%0.46×
Auditor registered in CVRYes · bankruptcy rate 4.8%0.55×
Audit opted outNo · bankruptcy rate 4.8%0.55×
Registered owners4+ · bankruptcy rate 5.7%0.65×
Reporting classReporting class B · bankruptcy rate 5.7%0.65×
Has a boardYes · bankruptcy rate 6.0%0.68×

The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.

Company details

CVR number
44512971
Status
Active
Company type
Private limited company (ApS)
Founded
(2 years)
Address
c/o Torben Hald, Ole Maaløes Vej 3
2200 København N
Municipality
København
Industry
Fremstilling af farmaceutiske præparater (212000)
Bankruptcies in the industry: Fremstilling af farmaceutiske præparater
Share capital
DKK 40k
Auditor
PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB
Audit opted out
No

Warning signs

Annual reports filed late1 of 2
Missing annual reportNo
Negative equityYes
Equity ratio-63.5%
Current ratio415%
Moves (last 2 years)1
CEO changes in total4
CEO's previous bankruptcies0
Other companies at the address167
Going-concern uncertaintyNo

Financials and key figures

Financial year20262025
Gross profitDKK -2.2mDKK 470k
Net profitDKK -4.2mDKK -196k
EquityDKK -5.0mDKK -156k
Total assetsDKK 7.9mDKK 5.3m
CashDKK 7.0mDKK 4.3m
Short-term debtDKK 1.9mDKK 1.5m
Avg. employees50

Latest annual report: Reporting class B · auditor's statement: Erklæring om udvidet gennemgang · PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab.

Filed annual reports

Reporting periodPublishedDays after period end
1 Apr 2025 – 31 Mar 2026136
19 Dec 2023 – 31 Mar 2025186 Late

The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.

Management, owners and auditor

RoleNameFromTo
CEOThomas Frees ButhlerCurrent
CEOAnders Miki BojesenCurrent
CEOFabio AntenucciCurrent
CEOThomas Frees Buthler
BoardThomas Frees ButhlerCurrent
BoardAnders Miki BojesenCurrent
BoardTorben HaldCurrent
BoardFabio AntenucciCurrent
Owner (25%)Copenhagen Equity ApSCurrent
Owner (25%)North2k ApSCurrent
Owner (25%)TBU Holding 2023 ApSCurrent
Owner (25%)HAVITO ASCurrent
AuditorPRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKABCurrent
FounderCopenhagen Equity ApSCurrent
FounderNorth2k ApSCurrent
FounderTBU Holding 2023 ApSCurrent
FounderHAVITO ASCurrent

The CEOs' other companies

Thomas Frees Buthler – 2 other companies

Anders Miki Bojesen – 4 other companies

Fabio Antenucci – 1 other companies

Address history (2 moves)

c/o Torben Hald, Ole Maaløes Vej 3, 2200 København N
c/o Torben Hald, Thorvaldsensvej 57, 1871 Frederiksberg C
Engelstedsgade 27, st., 2100 København Ø

Other companies at the same address

Similar companies in København

Questions and answers about Gefjon Pharma ApS

Has Gefjon Pharma ApS gone bankrupt?

No, Gefjon Pharma ApS is not registered as bankrupt in the CVR register. Its status is: active.

What is the bankruptcy risk of Gefjon Pharma ApS?

Our model estimates a bankruptcy risk of 0.6% over the next 12 months (low risk), which is 0.4 times the average for Danish companies.

Who is the CEO of Gefjon Pharma ApS?

Thomas Frees Buthler, Anders Miki Bojesen, Fabio Antenucci are the CEOs of Gefjon Pharma ApS.

Who is the auditor of Gefjon Pharma ApS?

Gefjon Pharma ApS most recently used PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB.

When was Gefjon Pharma ApS founded?

Gefjon Pharma ApS was founded on 19 December 2023.

What is the equity of Gefjon Pharma ApS?

Equity was DKK -5.0m according to the annual report for the period ending 31 March 2026.

Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.